group VI iPLA2 Inhibitors

Phospholipase A2s (PLA2s) constitute a family of esterases that hydrolyze the sn-2-acyl ester bond in glycerophospholipid molecules. Biochemicals that inhibit group VI iPLA2 have many applications in biochemical and physiological research. Click on the product name to view detailed information such as the chemical structure and specific chemical properties for each of our group VI iPLA2 Inhibitors. In stock group VI iPLA2 Inhibitors are available for immediate shipping.

indicates a highly recommended product based on customer preference.

PRODUCT NAME/Application CAS Catalog # QUANTITY Price Citations RATING
A cPLA2, anandamide hydrolysis, and FAAH inhibitor
149301-79-1 sc-201412
10 mg
50 mg
An inhibitor of Ca2+-dependent cytosolic cPLA2
141022-99-3 sc-201414
10 mg
50 mg
HELSS (Haloenol lactone suicide substrate, BEL, Bromoenol lactone)
An inhibitor of Ca-independent PLA2 and Mg-dependent PAP
88070-98-8 sc-201418
5 mg
25 mg
A potent, irreversible inhibitor of fatty acid amide hydrolase
188404-10-6 sc-203440
5 mg
(S)-Bromoenol lactone
An irreversible, chiral, mechanism-based inhibitor of calcium-independent phospholipase
478288-94-7 sc-222281
500 µg
1 mg

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.